GlassScriptPhysician profile
Matthew K Shotwell
NPI 1912975608
$70,658.98
in general payments reported to CMS, 2019-2025
38 companies · $2,111 in 2025
The $2,111 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52K · 2020: $3,729 · 2021: $8,957 · 2022: $1,234 · 2023: $972 · 2024: $1,896 · 2025: $2,111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,513 · Travel and Lodging: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,512.77 |
| Travel and Lodging | $466.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $61,150.18 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $2,671.88 | 2019-2025 | Lifevest |
| Cvrx, INC. | $856.01 | 2024 | Barostim Neo System |
| Boston Scientific Corporation | $768.99 | 2019-2024 | Dynagen Mini Icd Vr, Bodyguardian |
| Novartis Pharmaceuticals Corporation | $700.57 | 2019-2025 | |
| Endotronix, INC. | $608.78 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Medtronic, INC. | $586.44 | 2021-2025 | Symplicity G3, Onyx Frontier |
| Penumbra, INC. | $468.00 | 2024-2025 | Indigo System |
| Merck Sharp & Dohme LLC | $437.41 | 2021-2024 | Verquvo |
| Abbott Laboratories | $432.25 | 2019-2025 | Ensite Precision, Aveir, Gallant |
| Amgen INC. | $363.97 | 2021-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $331.30 | 2019-2023 | Farxiga |
| Shockwave Medical, INC | $324.17 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Angiodynamics, INC. | $188.54 | 2025 | Auryon Laser System 100-120 Vac |
| Boehringer Ingelheim Pharmaceuticals, INC. | $137.15 | 2021-2023 | Jardiance |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $129.53 | 2022-2024 | Optimizer |
| Novo Nordisk INC | $78.36 | 2022-2023 | Ozempic, Rybelsus |
| Cleerly, INC. | $56.65 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Baxter Healthcare | $54.23 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Abiomed | $33.17 | 2025 | |
| Medtronic Vascular, INC. | $26.89 | 2019-2020 | |
| Chiesi USA, INC. | $24.80 | 2023 | Kengreal |
| Actelion Pharmaceuticals US, INC. | $22.91 | 2023 | Opsumit, Uptravi |
| Pfizer INC. | $22.52 | 2021 | |
| United Therapeutics Corporation | $21.23 | 2024 | Remodulin |
| Amryt Pharma Holdings LTD | $17.66 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.99 | 2025 | |
| Atricure, INC. | $14.84 | 2024 | |
| Terumo Medical Corporation | $13.81 | 2022 | |
| Ethicon US, LLC | $13.55 | 2023 | Ethicon, Stratafix |
| Octapharma USA, INC. | $13.47 | 2025 | Balfaxar |
| E.R. Squibb & Sons, L.L.C. | $13.26 | 2021 | |
| Inari Medical, INC. | $12.93 | 2020 | |
| Medicure Pharma INC. | $12.44 | 2022 | |
| Verge Medical, INC. | $11.90 | 2021 | |
| Cmp Pharma, INC. | $11.23 | 2021 | |
| Bardy Diagnostics, INC. | $10.36 | 2020 | |
| Cagent Vascular INC | $2.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Shotwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.